1. Home
  2. REGN vs NOC Comparison

REGN vs NOC Comparison

Compare REGN & NOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

HOLD

Current Price

$796.95

Market Cap

68.8B

Sector

Health Care

ML Signal

HOLD

Logo Northrop Grumman Corporation

NOC

Northrop Grumman Corporation

HOLD

Current Price

$578.25

Market Cap

81.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
REGN
NOC
Founded
1988
1939
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
68.8B
81.8B
IPO Year
1995
2002

Fundamental Metrics

Financial Performance
Metric
REGN
NOC
Price
$796.95
$578.25
Analyst Decision
Buy
Buy
Analyst Count
25
16
Target Price
$830.16
$697.38
AVG Volume (30 Days)
764.3K
849.8K
Earning Date
04-29-2026
04-21-2026
Dividend Yield
0.55%
1.61%
EPS Growth
8.19
2.61
EPS
18.95
13.83
Revenue
$5,872,227,000.00
$41,954,000,000.00
Revenue This Year
$12.45
$5.68
Revenue Next Year
$10.13
$6.20
P/E Ratio
$42.06
$41.63
Revenue Growth
20.82
2.24
52 Week Low
$541.00
$479.02
52 Week High
$821.11
$774.00

Technical Indicators

Market Signals
Indicator
REGN
NOC
Relative Strength Index (RSI) 77.83 67.92
Support Level $738.17 $545.34
Resistance Level $818.06 $584.95
Average True Range (ATR) 21.79 12.31
MACD 7.78 4.39
Stochastic Oscillator 91.45 94.99

Price Performance

Historical Comparison
REGN
NOC

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

About NOC Northrop Grumman Corporation

Northrop Grumman is a diversified defense contractor providing aeronautics, defense, and space systems. The company's aerospace segment produces autonomous and piloted aircraft such as Global Hawk drones and the new B-21 bomber, creates the fuselage for the massive F-35 program, and maintains and upgrades numerous other military aircraft. Defense systems makes artillery and missile ammunition and guidance systems, long-range missiles, and missile defense systems. Mission systems creates and integrates a variety of radar, navigation, and communication systems for avionics, weapons control, and countermeasures on a range of platforms from helicopters to destroyers. Space systems produces satellites, sensors, space structures, and rocket motors.

Share on Social Networks: